Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy

Authors: Jonathan Fraportti do Nascimento, Luis H Canani, Fernando Gerchman, Patricia G Rodrigues, Gabriel Joelsons, Mariane dos Santos, Sane Pereira, Francisco V Veronese

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

To investigate gene expression of podocyte-specific proteins in urine of diabetes and prediabetes subjects and the association of these proteins with albuminuria.

Methods

Fifteen controls, 19 prediabetes, and 67 diabetes subjects were included. Messenger RNA of nephrin, podocin, podocalyxin, synaptopodin, TRPC6, alpha-actinin-4, and TGF-β1 were measured using RT-PCR. Podocyte marker expression was correlated with albuminuria, glycemic control, and renal function. The diagnostic performance of the genes used to detect increased albuminuria was assessed using ROC curves and Poisson regressions.

Results

Podocyte marker expression was significantly higher in diabetic subjects. Urinary nephrin was correlated with increasing levels of albuminuria; risk of albuminuria increased by 20% for every one-unit increase in the log10 of nephrin mRNA. Nephrinuria was found in 53%, 71%, and 90% of normo-, micro-, and macroalbuminuric diabetes subjects, respectively (p = 0.023). Urinary nephrin, podocalyxin, TRPC6, podocin, and alpha actinin-4 were correlated with glycemic control and albuminuria but not with renal function.

Conclusions

Diabetes subjects had higher urinary mRNA levels of podocyte proteins than nondiabetic subjects, even the normoalbuminuric patients. Nephrinuria was correlated with diabetic nephrophathy stage and predicted pathological albuminuria. Urinary mRNA levels of podocyte markers of prediabetic subjects did not differ from controls.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sesso RC, Lopes AA, Thomé FS, Lugon JR, Santos DR: 2010 report of the Brazilian dialysis census. J Bras Nefrol. 2011, 33: 442-447. 10.1590/S0101-28002011000400009.CrossRefPubMed Sesso RC, Lopes AA, Thomé FS, Lugon JR, Santos DR: 2010 report of the Brazilian dialysis census. J Bras Nefrol. 2011, 33: 442-447. 10.1590/S0101-28002011000400009.CrossRefPubMed
2.
go back to reference Diez-Sampedro A, Lenz O, Fornoni A: Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis. 2011, 58: 637-646. 10.1053/j.ajkd.2011.03.035.CrossRefPubMedPubMedCentral Diez-Sampedro A, Lenz O, Fornoni A: Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis. 2011, 58: 637-646. 10.1053/j.ajkd.2011.03.035.CrossRefPubMedPubMedCentral
3.
go back to reference Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005, 54: 1626-1634. 10.2337/diabetes.54.6.1626.CrossRefPubMed Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005, 54: 1626-1634. 10.2337/diabetes.54.6.1626.CrossRefPubMed
4.
go back to reference Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M: Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes. 2007, 56: 2155-2160. 10.2337/db07-0019.CrossRefPubMed Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M: Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes. 2007, 56: 2155-2160. 10.2337/db07-0019.CrossRefPubMed
5.
go back to reference Susztak K, Raff AC, Schiffer M, Bottinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006, 55: 225-233. 10.2337/diabetes.55.01.06.db05-0894.CrossRefPubMed Susztak K, Raff AC, Schiffer M, Bottinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006, 55: 225-233. 10.2337/diabetes.55.01.06.db05-0894.CrossRefPubMed
6.
go back to reference Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, et al: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol. 2003, 162: 1123-1137. 10.1016/S0002-9440(10)63909-0.CrossRefPubMedPubMedCentral Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, et al: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol. 2003, 162: 1123-1137. 10.1016/S0002-9440(10)63909-0.CrossRefPubMedPubMedCentral
7.
go back to reference Schrijvers BF, De Vriese AS, Flyvbjerg A: From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev. 2004, 25: 971-1010. 10.1210/er.2003-0018.CrossRefPubMed Schrijvers BF, De Vriese AS, Flyvbjerg A: From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev. 2004, 25: 971-1010. 10.1210/er.2003-0018.CrossRefPubMed
8.
go back to reference Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol. 2005, 16: 408-416. 10.1681/ASN.2004070564.CrossRefPubMed Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol. 2005, 16: 408-416. 10.1681/ASN.2004070564.CrossRefPubMed
9.
go back to reference Petermann A, Floege J: Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract. 2007, 106: 61-66. 10.1159/000101799.CrossRef Petermann A, Floege J: Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract. 2007, 106: 61-66. 10.1159/000101799.CrossRef
10.
go back to reference Skoberne A, Konieczny A, Schiffer M: Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol. 2009, 296: 230-241.CrossRef Skoberne A, Konieczny A, Schiffer M: Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol. 2009, 296: 230-241.CrossRef
11.
go back to reference Barisoni L, Schnaper W, Koop JB: Advances in the biology and genetics of the podocytopathies. Arch Pathol Lab Med. 2009, 133: 201-216.PubMedPubMedCentral Barisoni L, Schnaper W, Koop JB: Advances in the biology and genetics of the podocytopathies. Arch Pathol Lab Med. 2009, 133: 201-216.PubMedPubMedCentral
12.
go back to reference Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, et al: Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 2007, 18: 29-36. 10.1681/ASN.2006091010.CrossRefPubMed Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, et al: Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 2007, 18: 29-36. 10.1681/ASN.2006091010.CrossRefPubMed
13.
go back to reference Chen S, Jim B, Ziyadeh FN: Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol. 2003, 23: 532-543. 10.1053/S0270-9295(03)00132-3.CrossRefPubMed Chen S, Jim B, Ziyadeh FN: Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol. 2003, 23: 532-543. 10.1053/S0270-9295(03)00132-3.CrossRefPubMed
14.
go back to reference Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, et al: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant. 2000, 15: 1379-1383. 10.1093/ndt/15.9.1379.CrossRefPubMed Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, et al: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant. 2000, 15: 1379-1383. 10.1093/ndt/15.9.1379.CrossRefPubMed
15.
go back to reference Wang G, Lai FM, Lai KB, Chow KM, Li KT, Szeto CC: Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract. 2007, 106: 169-179. 10.1159/000104428.CrossRef Wang G, Lai FM, Lai KB, Chow KM, Li KT, Szeto CC: Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract. 2007, 106: 169-179. 10.1159/000104428.CrossRef
16.
go back to reference Ng DP, Tai BC, Tan E, Leong H, Nurbaya S, Lim XL, et al: Nephrinuria associates with multiple renal traits in type 2 diabetes. Nephrol Dial Transplant. 2011, 26: 2508-2514. 10.1093/ndt/gfq738.CrossRefPubMed Ng DP, Tai BC, Tan E, Leong H, Nurbaya S, Lim XL, et al: Nephrinuria associates with multiple renal traits in type 2 diabetes. Nephrol Dial Transplant. 2011, 26: 2508-2514. 10.1093/ndt/gfq738.CrossRefPubMed
17.
go back to reference Xing Y, Ye S, Hu Y, Chen Y: Podocyte as a potential target of inflammation: role of hydrochloride pioglitazone in type 2 diabetics. Endocrinol Pract. 2012, 18: 493-498. 10.4158/EP11378.OR.CrossRef Xing Y, Ye S, Hu Y, Chen Y: Podocyte as a potential target of inflammation: role of hydrochloride pioglitazone in type 2 diabetics. Endocrinol Pract. 2012, 18: 493-498. 10.4158/EP11378.OR.CrossRef
18.
go back to reference Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, et al: Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol. 2008, 158: 317-322. 10.1530/EJE-07-0708.CrossRefPubMed Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, et al: Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol. 2008, 158: 317-322. 10.1530/EJE-07-0708.CrossRefPubMed
19.
go back to reference American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010, 33: 62-69.CrossRef American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010, 33: 62-69.CrossRef
20.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150: 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150: 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral
21.
22.
go back to reference Marshall SM: The podocyte: a potential therapeutic target in diabetic nephropathy?. Curr Pharma Des. 2007, 13: 2713-2720. 10.2174/138161207781662957.CrossRef Marshall SM: The podocyte: a potential therapeutic target in diabetic nephropathy?. Curr Pharma Des. 2007, 13: 2713-2720. 10.2174/138161207781662957.CrossRef
23.
go back to reference Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, et al: Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes. 2003, 52: 1023-1030. 10.2337/diabetes.52.4.1023.CrossRefPubMed Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, et al: Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes. 2003, 52: 1023-1030. 10.2337/diabetes.52.4.1023.CrossRefPubMed
24.
go back to reference Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, et al: Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007, 72: 1262-1272. 10.1038/sj.ki.5002531.CrossRefPubMed Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, et al: Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007, 72: 1262-1272. 10.1038/sj.ki.5002531.CrossRefPubMed
25.
go back to reference Steffes MW, Schmidt D, McCrery R, Basgen JM: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001, 59: 2104-2113.CrossRefPubMed Steffes MW, Schmidt D, McCrery R, Basgen JM: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001, 59: 2104-2113.CrossRefPubMed
26.
go back to reference Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS, et al: Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta. 2005, 361: 182-190. 10.1016/j.cccn.2005.05.016.CrossRefPubMed Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS, et al: Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta. 2005, 361: 182-190. 10.1016/j.cccn.2005.05.016.CrossRefPubMed
27.
go back to reference Vogelmann SU, Nelson WJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003, 285: 40-48.CrossRef Vogelmann SU, Nelson WJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003, 285: 40-48.CrossRef
28.
go back to reference Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL, et al: Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One. 2011, 6: 20431-10.1371/journal.pone.0020431.CrossRef Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL, et al: Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One. 2011, 6: 20431-10.1371/journal.pone.0020431.CrossRef
29.
go back to reference Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P: Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003, 52: 1031-1035. 10.2337/diabetes.52.4.1031.CrossRefPubMed Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P: Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003, 52: 1031-1035. 10.2337/diabetes.52.4.1031.CrossRefPubMed
30.
go back to reference Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia. 1999, 42: 1341-1344. 10.1007/s001250051447.CrossRefPubMed Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia. 1999, 42: 1341-1344. 10.1007/s001250051447.CrossRefPubMed
31.
go back to reference White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi , Piras GP, et al: Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes. 2002, 51: 3083-3089. 10.2337/diabetes.51.10.3083.CrossRefPubMed White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi , Piras GP, et al: Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes. 2002, 51: 3083-3089. 10.2337/diabetes.51.10.3083.CrossRefPubMed
32.
go back to reference Benigni A, Gagliardini E, Tomasoni S, et al: Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int. 2004, 65: 2193-2200. 10.1111/j.1523-1755.2004.00636.x.CrossRefPubMed Benigni A, Gagliardini E, Tomasoni S, et al: Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int. 2004, 65: 2193-2200. 10.1111/j.1523-1755.2004.00636.x.CrossRefPubMed
33.
go back to reference Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, et al: Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One. 2012, 7: e36041-10.1371/journal.pone.0036041.CrossRefPubMedPubMedCentral Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, et al: Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One. 2012, 7: e36041-10.1371/journal.pone.0036041.CrossRefPubMedPubMedCentral
34.
go back to reference Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, et al: Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am J Physiol Cell Physiol. 2011, 301: 304-315. 10.1152/ajpcell.00014.2011.CrossRef Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, et al: Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am J Physiol Cell Physiol. 2011, 301: 304-315. 10.1152/ajpcell.00014.2011.CrossRef
35.
go back to reference Patäri A, Forsblom C, Havana M, Taipale H, Groop PH, et al: Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes. 2003, 52: 2969-2974. 10.2337/diabetes.52.12.2969.CrossRefPubMed Patäri A, Forsblom C, Havana M, Taipale H, Groop PH, et al: Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes. 2003, 52: 2969-2974. 10.2337/diabetes.52.12.2969.CrossRefPubMed
36.
go back to reference Lemley KV, Blouch K, Abdullah I, Boothroyd DB, Bennett PH, Myers BD, et al: Glomerular permselectivety at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol. 2000, 11: 2095-2105.PubMed Lemley KV, Blouch K, Abdullah I, Boothroyd DB, Bennett PH, Myers BD, et al: Glomerular permselectivety at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol. 2000, 11: 2095-2105.PubMed
37.
go back to reference Kimura M, Toyoda M, Kato M, Kobayashi K, Abe M, Kobayashi T: Expression of alpha-actinin-4 in human diabetic nephropathy. Intern Med. 2008, 47: 1099-1106. 10.2169/internalmedicine.47.0352.CrossRefPubMed Kimura M, Toyoda M, Kato M, Kobayashi K, Abe M, Kobayashi T: Expression of alpha-actinin-4 in human diabetic nephropathy. Intern Med. 2008, 47: 1099-1106. 10.2169/internalmedicine.47.0352.CrossRefPubMed
38.
go back to reference Ha TS: High glucose and advanced glycosylated end products affect expression of alpha-actinin-4 in glomerular epithelial cells. Nephrology. 2006, 17: 57-68. Ha TS: High glucose and advanced glycosylated end products affect expression of alpha-actinin-4 in glomerular epithelial cells. Nephrology. 2006, 17: 57-68.
39.
go back to reference Dryer SE, Reiser J: TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol. 2010, 299: 689-701. 10.1152/ajprenal.00298.2010.CrossRef Dryer SE, Reiser J: TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol. 2010, 299: 689-701. 10.1152/ajprenal.00298.2010.CrossRef
40.
go back to reference WuDT BM, Ju W, Mundel P, Böttinger EP: TGFbeta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol. 2005, 16: 3211-3221. 10.1681/ASN.2004121055.CrossRef WuDT BM, Ju W, Mundel P, Böttinger EP: TGFbeta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol. 2005, 16: 3211-3221. 10.1681/ASN.2004121055.CrossRef
41.
go back to reference Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, et al: Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia. 2005, 48: 2650-2660. 10.1007/s00125-005-0006-5.CrossRefPubMed Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, et al: Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia. 2005, 48: 2650-2660. 10.1007/s00125-005-0006-5.CrossRefPubMed
42.
go back to reference Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Pinel N, et al: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in the diabetic nephropathy: effects of angiotensin converting enzyme I inhibition. Diabetologia. 2002, 45: 1572-1576. 10.1007/s00125-002-0946-y.CrossRefPubMed Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Pinel N, et al: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in the diabetic nephropathy: effects of angiotensin converting enzyme I inhibition. Diabetologia. 2002, 45: 1572-1576. 10.1007/s00125-002-0946-y.CrossRefPubMed
Metadata
Title
Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy
Authors
Jonathan Fraportti do Nascimento
Luis H Canani
Fernando Gerchman
Patricia G Rodrigues
Gabriel Joelsons
Mariane dos Santos
Sane Pereira
Francisco V Veronese
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-214

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.